Anticancer oncolytic activity of respiratory syncytial virus

Cancer Gene Therapy

Volumn 16, Issue 12, 2009, Pages 923-935

  Echchgadda, I ^a   Kota, S ^a   Dela Cruz, I ^a   Sabbah, A ^a   Chang, T ^a   Harnack, R ^a   Mgbemena, V ^a   Chatterjee, B ^a,b   Bose, S ^a  

^a Mays Cancer Center at UT Health San Antonio   (United States)

^b SOUTH TEXAS VETERANS HEALTH CARE SYSTEM   (United States)

Author keywords

Anticancer; Apoptosis; Oncolytic; Prostate cancer; Respiratory syncytial virus

Indexed keywords

ANDROGEN; CASPASE 3; DEATH RECEPTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; ONCOLYTIC VIRUS; PROTEIN BAD; PROTEIN BAX; PROTEIN BCL 2; PROTEIN BCL XL; PROTEIN KINASE B; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; AUTOCRINE EFFECT; CANCER CELL DESTRUCTION; CANCER GROWTH; CANCER REGRESSION; CONTROLLED STUDY; DOWN REGULATION; ENDOPLASMIC RETICULUM STRESS; HUMAN; HUMAN CELL; METASTASIS; MITOCHONDRION; MOUSE; NONHUMAN; ONCOLYTIC VIROTHERAPY; PARACRINE SIGNALING; PRIORITY JOURNAL; PROSTATE CANCER; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; TREATMENT OUTCOME; TUMOR XENOGRAFT; VIRUS INFECTIVITY;

ANIMALS; APOPTOSIS; CASPASE 12; CASPASE 3; CELL LINE, TUMOR; ENZYME ACTIVATION; HUMANS; MALE; MICE; MICE, NUDE; MITOCHONDRIA; NF-KAPPA B; ONCOLYTIC VIROTHERAPY; PROSTATIC NEOPLASMS; PROTO-ONCOGENE PROTEINS C-AKT; RESPIRATORY SYNCYTIAL VIRUSES; TNF-RELATED APOPTOSIS-INDUCING LIGAND; XENOGRAFT MODEL ANTITUMOR ASSAYS;

HUMAN RESPIRATORY SYNCYTIAL VIRUS; MUS MUSCULUS; RESPIRATORY SYNCYTIAL VIRUS; RICE STRIPE VIRUS;

EID: 70449641036     PISSN: 09291903     EISSN: 14765500     Source Type: Journal    
DOI: 10.1038/cgt.2009.34     Document Type: Article

References (46)

1. Parato KA, Senger D, Forsyth PA, Bell JC. Recent progress in the battle between oncolytic viruses and tumours. Nat Rev Cancer 2005; 5: 965-966.
2. Bell JC. Oncolytic viruses: what's next? Curr Cancer Drug Targets 2007; 7: 127-131.
3. Stanford MM, McFadden G. Myxoma virus and oncolytic virotherapy: a new biologic weapon in the war against cancer. Expert Opin Biol Ther 2007; 7: 1415-1425.
4. Collins PL, Chanock RM, Murphy BR, Knipe DM, Howley PM (eds). Fields Virology. Lippincott Williams & Wilkins: Philadelphia, 2001: 1443-1486.
5. Cane P, Zuckerman AJ, Mushahwar IK. Perspectives in Medical Virology. Elsevier Science Ltd: Amsterdam, 2006: 1-340.
6. Fielding AK. Measles as a potential oncolytic virus. Rev Med Virol 2005; 15: 135-142.
7. Lorence RM, Katubig BB, Reichard KW, Reyes HM, Phuangsab A, Sassetti MD et al. Complete regression of human fibrosarcoma xenografts after local Newcastle disease virus therapy. Cancer Res 1994; 54: 6017-6021. (Pubitemid 24378619)
8. Lorence RM, Roberts MS, O'Neil JD, Groene WS, Miller JA, Mueller SN et al. Phase 1 clinical experience using intravenous administration of PV701, an oncolytic Newcastle disease virus. Curr Cancer Drug Targets 2007; 7: 157-167.
9. Meng XW, Lee SH, Kaufmann SH. Apoptosis in the treatment of cancer: a promise kept? Curr Opin Cell Biol 2006; 18: 668-676.
10. Vermeulen K, Van Bockstaele DR, Berneman ZN. Apopto-sis: mechanisms and relevance in cancer. Ann Hematol 2005; 84: 627-639.
11. Kidd VJ. Proteolytic activities that mediate apoptosis. Annu Rev Physiol 1998; 60: 533-573.
12. Chu ZL, Pio F, Xie Z, Welsh K, Krajewska M, Krajewski S et al. A novel enhancer of the Apaf1 apoptosome involved in cytochrome c-dependent caspase activation and apoptosis. J Biol Chem 2001; 276: 9239-9245.
13. Budihardjo I, Oliver H, Lutter M, Luo X, Wang X. Biochemical pathways of caspase activation during apopto-sis. Annu Rev Cell Dev Biol 1999; 15: 269-290.
14. Franke TF, Hornik CP, Segev L, Shostak GA, Sugimoto C. PI3K/Akt and apoptosis: size matters. Oncogene 2003; 22: 8983-8998.
15. Barkett M, Gilmore TD. Control of apoptosis by Rel/NF-kappaB transcription factors. Oncogene 1999; 18: 6910-6924.
16. Bischoff JR, Kirn DH, Williams A, Heise C, Horn S, Muna M et al. An adenovirus mutant that replicates selectively in p53-deficient human tumor cells. Science 1996; 274: 373-376.
17. Harada N, Maniwa Y, Yoshimura M, Nagata M, Hamada H, Yokono K et al. E1B-deleted adenovirus replicates in p53-deficient lung cancer cells due to the absence of apoptosis. Oncol Rep 2005; 5: 1155-1163.
18. Chatterjee B. The role of the androgen receptor in the development of prostatic hyperplasia and prostate cancer. Mol Cell Biochem 2003; 253: 89-101.
19. Suh J, Rabson AB. NF-kappaB activation in human prostate cancer: important mediator or epiphenomenon? J Cell Biochem 2004; 91: 100-117.
20. Suh J, Payvandi F, Edelstein LC, Amenta PS, Zong WX, Gelinas C et al. Mechanisms of constitutive NF-kappaB activation in human prostate cancer cells. Prostate 2002; 52: 183-200.
21. Coppe JP, Itahana Y, Moore DH, Bennington JL, Desprez PY. Id-1 and Id-2 proteins as molecular markers for human prostate cancer progression. Clin Cancer Res 2004; 10: 2044-2051.
22. Yang M, Jiang P, Sun FX, Hasegawa S, Baranov E, Chishima T et al. A fluorescent orthotopic bone metastasis model of human prostate cancer. Cancer Res 1999; 59: 781-786.
23. Bose S, Kar N, Maitra R, DiDonato JA, Banerjee AK. Temporal activation of NF-kB regulates an interferon-independent innate antiviral response against cytoplasmic RNA viruses. Proc Natl Acad Sci USA 2003; 100: 10890-10895.
24. Bose S, Basu M, Banerjee AK. Role of nucleolin in human parainfluenza virus type 3 infection of human lung epithelial cells. J Virol 2004; 78: 8146-8158.
25. Kota S, Sabbah A, Chang TH, Harnack R, Xiang Y, Meng Y et al. Role of human b-defensin-2 during tumor necrosis factor-a/NF-kB-mediated innate antiviral response against human respiratory syncytial virus. J Biol Chem 2008; 283: 22417-22429.
26. Pauwels R, Balzarini J, Baba M, Snoeck R, Schols D, Herdewijn P et al. Rapid and automated tetrazolium-based colorimetric assay for the detection of anti-HIV compounds. J Virol Methods 1988; 20: 309-321.
27. Muruganandham M, Alfieri AA, Matei C, Chen Y, Sukenick G, Schemainda I et al. Metabolic signatures associated with a NAD synthesis inhibitor-induced tumor apoptosis identified by 1H-decoupled-31P magnetic resonance spectroscopy. Clin Cancer Res 2005; 11: 3503-3513.
28. Bose S, Malur A, Banerjee AK. Polarity of human parainfluenza virus type 3 infection in polarized human lung epithelial A549 cells: role of microfilament and microtubule. J Virol 2001; 75: 1984-1989.
29. Jounaidi Y, Waxman DJ. Use of replication-conditional adenovirus as a helper system to enhance delivery of P450 prodrug-activation genes for cancer therapy. Cancer Res 2004; 64: 292-303.
30. Hallak LK, Collins PL, Knudson W, Peeples ME. Iduronic acid-containing glycosaminoglycans on target cells are required for efficient respiratory syncytial virus infection. Virology 2000; 271: 264-275.
31. Szegezdi E, Fitzgerald U, Sanamali A. Caspase-12 and ER-stress-mediated apoptosis: the story so far. Ann NY Acad Sci 2003; 1010: 186-194.
32. Bitko V, Barik S. An endoplasmic reticulum-specific stress-activated caspase (caspase-12) is implicated in the apoptosis of A549 epithelial cells by respiratory syncytial virus. J Cell Biochem 2001; 80: 441-454.
33. Kim KB, Choi YH, Kim IK, Chung CW, Kim BJ, Park YM et al. Potentiation of Fas-and TRAIL-mediated apoptosis by IFN-gamma in A549 lung epithelial cells: enhancement of caspase-8 expression through IFN-response element. Cyto-kine 2002; 20: 283-288.
34. Jiang Z, Kunimoto M, Patel JA. Autocrine regulation and experimental modulation of interleukin-6 expression by human pulmonary epithelial cells infected with respiratory syncytial virus. J Virol 1998; 72: 2496-2499.
35. Thomas KW, Monick MM, Staber JM, Yarovinsky T, Carter AB, Hunninghake GW. Respiratory syncytial virus inhibits apoptosis and induces NF-kappa B activity through a phosphatidylinositol 3-kinase-dependent pathway. J Biol Chem 2002; 277: 492-501.
36. Lindemans CA, Coffer PJ, Schellens IM, de Graaff PM, Kimpen JL, Koenderman L. Respiratory syncytial virus inhibits granulocyte apoptosis through a phosphatidylinosi-tol 3-kinase and NF-kappaB-dependent mechanism. J Immunol 2006; 176: 5529-5537.
37. Mori A, Lehmann S, O'Kelly J, Kumagai T, Desmond JC, Pervan M et al. Capsaicin, a component of red peppers, inhibits the growth of androgen-independent, p53 mutant prostate cancer cells. Cancer Res 2006; 66: 3222-3229.
38. Orlandi A, Francesconi A, Marcellini M, Di Lascio A, Spagnoli LG. Propionyl-L-carnitine reduces proliferation and potentiates Bax-related apoptosis of aortic intimal smooth muscle cells by modulating nuclear factor-kappaB activity. J Biol Chem 2007; 282: 4932-4942.
39. Naderi A, Teschendorff AE, Beigel J, Cariati M, Ellis IO, Brenton JD et al. BEX2 is overexpressed in a subset of primary breast cancers and mediates nerve growth factor/ nuclear factor-kappaB inhibition of apoptosis in breast cancer cell lines. Cancer Res 2007; 67: 6725-6736.
40. Zhang L, Peeples ME, Boucher RC, Collins PL, Pickles RJ. Respiratory syncytial virus infection of human airway epithelial cells is polarized, specific to ciliated cells, and without obvious cytopathology. J Virol 2002; 76: 5654-5666.
41. Roberts SR, Compans RW, Wertz GW. Respiratory syncytial virus matures at the apical surfaces of polarized epithelial cells. J Virol 1995; 69: 2667-2673.
42. Murphy BR, Collins PL. Live-attenuated virus vaccines for respiratory syncytial and parainfluenza viruses: applications of reverse genetics. J Clin Invest 2002; 110: 21-27.
43. Yu R, Mandlekar S, Ruben S, Ni J, Kong AN. Tumor necrosis factor-related apoptosis-inducing ligand-mediated apoptosis in androgen-independent prostate cancer cells. Cancer Res 2000; 60: 2384-2389.
44. Subbarayan V, Sabichi AL, Llansa N, Lippman SM, Menter DG. Differential expression of cyclooxygenase-2 and its regulation by tumor necrosis factor-alpha in normal and malignant prostate cells. Cancer Res 2001; 61: 2720-2726.
45. Yu R, Mandlekar S, Ruben S, Ni J, Kong A-N. Tumor necrosis factor related apoptosis-inducing ligand-mediated apoptosis in androgen-independent prostate cancer cells. Cancer Res 2000; 60: 2384-2389.
46. Roy S, Nicholson DW. Cross-talk in cell death signaling. J Exp Med 2000; 192: F21-F25.